AOD-9604 Nasal Spray
15ml · 99%+ Purity
HPLC Tested
99%+ Purity
About Our Testing
Every batch is tested by our manufacturer using HPLC analysis. Per-batch third-party testing adds significant cost and delays that would be passed to customers.
Fast Shipping
Same-day dispatch
Description
AOD-9604 nasal spray 15ml at 99%+ purity. Convenient daily delivery for fat metabolism and weight loss research.
Research Use Only: This product is intended for laboratory research purposes only. Not for human consumption.
Research & Science
Evidence-based information about this compound
Chemical Properties
Molecular Formula
C78H123N23O23S2
Molecular Weight
1815.1 g/mol
Amino Acid Sequence
Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
Also known as:
AOD 9604, Anti-Obesity Drug 9604, HGH Fragment 176-191
AOD-9604 Nasal Spray delivers the same modified fragment of human growth hormone through a convenient intranasal route. This formulation provides an alternative delivery method that offers rapid absorption without the need for injection.
The nasal mucosa provides a highly vascularized absorption surface with direct access to systemic circulation. Each spray delivers a precise, measured dose, making administration simple and consistent.
AOD-9604 represents amino acids 176-191 of the HGH molecule, the region identified as responsible for fat metabolism effects, modified with a tyrosine at the N-terminus for enhanced stability.
Intranasal AOD-9604 works through the same mechanisms as injectable forms:
- Lipolytic Activity: Stimulates lipolysis (fat breakdown) through beta-3 adrenergic receptor pathways.
- Lipogenesis Inhibition: Prevents new fat cell formation by blocking lipogenic enzymes.
- Metabolic Effects: Influences fat metabolism without affecting IGF-1 or blood glucose levels.
- Rapid Absorption: Nasal delivery provides quick absorption into systemic circulation.
AOD-9604 has been studied extensively for its fat metabolism effects:
- Lipolysis: Stimulates fat breakdown in adipose tissue.
- Lipogenesis: Reduces new fat formation.
- Metabolic Safety: Does not affect IGF-1, insulin, or glucose levels.
- Clinical Studies: Has undergone Phase 2 clinical trials for obesity.
These properties make AOD-9604 valuable for metabolism research.
Sources:
This information is provided for educational purposes only and is based on published scientific research. This product is intended for research use only.
